DalsnaFinance › IPOs › Tarsus Pharmaceuticals Inc › IPO
Tarsus Pharmaceuticals, Inc. completed its initial public offering on NASDAQ on October 16, 2020, pricing at $16.00 a share.
| Ticker | TARS |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | October 16, 2020 |
| Offering price | $16.00 |
| Shares offered | 5,500,000 |
| Total raised | $88M |
Tarsus Pharmaceuticals, Inc. sold 5,500,000 shares at $16.00 each on NASDAQ. Multiplied out, that is $88 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $88 million total recorded for the deal.
Tarsus Pharmaceuticals, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Tarsus Pharmaceuticals, Inc.. This page is general information, not investment advice.